Free Access
Issue |
Med Sci (Paris)
Volume 19, Number 6-7, Juin-Juillet 2003
|
|
---|---|---|
Page(s) | 667 - 668 | |
Section | Le Magazine : Nouvelles | |
DOI | https://doi.org/10.1051/medsci/20031967667 | |
Published online | 15 June 2003 |
Med Sci (Paris) 2003 ; 19 : 667–668
L’imatinib mésylate : une révolution dans le traitement de la leucémie myéloïde chronique
Imatinib mesylate: a major breakthrough in the treatment of chronic myelogenous leukemia
Inserm U.362, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
Cet article ne possède pas de résumé.
© 2003 médecine/sciences - Inserm / SRMS
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
First page of the article